HPV vaccination in France: Uptake, costs and issues for the National Health Insurance

This publication has 14 references indexed in Scilit:

• Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark
  International Journal of Technology Assessment in Health Care, 2010
• Eligibility and willingness of first-year students entering university to participate in a HPV vaccination catch-up program
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 2010
• Pharmacoepidemiological research using French reimbursement databases: yes we can!
  Pharmacoepidemiology and Drug Safety, 2010
• Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
  British Journal of Cancer, 2010
• Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model
  Vaccine, 2008
• Modeling Cervical Cancer Prevention in Developed Countries
  Vaccine, 2008
• Economic evaluation of human papillomavirus vaccination in the United Kingdom
  BMJ, 2008
• Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland
  Current Medical Research and Opinion, 2008
• Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France
  International Journal of Technology Assessment in Health Care, 2008
• Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
  Published by Elsevier ,2007